Allurion Technologies Inc. (ALUR)
NYSE: ALUR · Real-Time Price · USD
0.6841
-0.0170 (-2.42%)
Mar 3, 2026, 4:00 PM EST - Market closed
Allurion Technologies Employees
As of December 31, 2024, Allurion Technologies had 137 total employees, including 134 full-time and 3 part-time employees. The number of employees decreased by 115 or -45.63% compared to the previous year.
Employees
137
Change (1Y)
-115
Growth (1Y)
-45.63%
Revenue / Employee
$125,606
Profits / Employee
-$235,971
Market Cap
8.40M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 137 | -115 | -45.63% | 134 | 3 |
| Dec 31, 2023 | 252 | -4 | -1.56% | 249 | 3 |
| Sep 30, 2023 | 268 | 12 | 4.69% | 268 | 0 |
| Jun 30, 2023 | 268 | - | - | 266 | 2 |
| Mar 31, 2023 | 256 | - | - | 252 | 4 |
| Dec 31, 2022 | 256 | - | - | 256 | 0 |
Related Stocks
| Company Name | Employees |
|---|---|
| Lifeward | 80 |
| Beyond Air | 61 |
| Intelligent Bio Solutions | 55 |
| Biomerica | 54 |
| enVVeno Medical | 37 |
| Tenon Medical | 27 |
| Sintx Technologies | 20 |
| HeartSciences | 15 |
ALUR News
- 1 day ago - Allurion Intends to Appeal NYSE Notice of Delisting, Execute Plan to Regain Compliance, and Expects to Continue Trading on NYSE - Business Wire
- 1 day ago - NYSE to Commence Delisting Proceedings Against Allurion Technologies, Inc. (ALUR) - Business Wire
- 7 days ago - Allurion Announces Exercise of Warrants for $3.0 Million in Gross Proceeds - Business Wire
- 8 days ago - Allurion Receives U.S. FDA Approval - Business Wire
- 4 weeks ago - Allurion Announces Partnership to Offer Combination Therapy with Mounjaro® (tirzepatide) at Discounted Prices - Business Wire
- 7 weeks ago - Allurion Announces Preliminary Fourth Quarter and Full-Year 2025 Results - Business Wire
- 3 months ago - Allurion Announces Initial Results on Combining the Allurion Program With Low-Dose Tirzepatide to Optimize Muscle Mass and GLP-1 Adherence - Business Wire
- 3 months ago - New Peer-Reviewed Publication Demonstrates Superior Weight Loss and Improved Body Composition with the Allurion Smart Capsule Combined with Lifestyle Intervention Compared to Lifestyle Intervention Alone - Business Wire